Literature DB >> 16041651

Antihepatitis activity (anti-HBsAg and anti-HBeAg) of C19 homolignans and six novel C18 dibenzocyclooctadiene lignans from Kadsura japonica.

Yao-Haur Kuo1, Ming-Der Wu, Ray-Ling Huang, Li-Ming Yang Kuo, Ya-Wen Hsu, Chia-Ching Liaw, Chia-Cheng Hung, Ya-Ching Shen, Chi-Wi Ong.   

Abstract

Bioassay-directed fractionation of the EtOAc extract of Kadsura japonica has led to the isolation of six new C18 dibenzocyclooctadiene lignans, schizanrins I, J, K, L, M, N, along with four known C19 homolignans, taiwanschirins A, B, C, and heteroclitin F. The elucidations of the new structures were based on spectral analysis. Bioassay evaluation against human type B hepatitis revealed that taiwanschirins A and B showed strong activity for anti-HBsAg and a medium effect for anti-HBeAg at 25 microg/mL (12.9 and 11.9 microM for taiwanschirins A and B, respectively).

Entities:  

Mesh:

Substances:

Year:  2005        PMID: 16041651     DOI: 10.1055/s-2005-871271

Source DB:  PubMed          Journal:  Planta Med        ISSN: 0032-0943            Impact factor:   3.352


  4 in total

1.  In silico Analysis and Experimental Validation of Lignan Extracts from Kadsura longipedunculata for Potential 5-HT1AR Agonists.

Authors:  Yaxin Zheng; Jiming Wu; Xuesong Feng; Ying Jia; Jian Huang; Zhihui Hao; Songyan Zhao; Jinhui Wang
Journal:  PLoS One       Date:  2015-06-15       Impact factor: 3.240

Review 2.  A review of lignans from genus Kadsura and their spectrum characteristics.

Authors:  Liu Zhang; Yan-Zhe Jia; Bin Li; Cai-Yun Peng; Yu-Pei Yang; Wei Wang; Chang-Xiao Liu
Journal:  Chin Herb Med       Date:  2021-03-02

Review 3.  Plant-derived lignans as potential antiviral agents: a systematic review.

Authors:  Xin-Ya Xu; Dong-Ying Wang; Yi-Ping Li; Stephen T Deyrup; Hong-Jie Zhang
Journal:  Phytochem Rev       Date:  2021-05-31       Impact factor: 7.741

Review 4.  Traditional Chinese herbal medicine as a source of molecules with antiviral activity.

Authors:  Ting Li; Tao Peng
Journal:  Antiviral Res       Date:  2012-11-12       Impact factor: 5.970

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.